These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9893619)

  • 1. Pharmacogenetics and cancer chemotherapy.
    Iyer L; Ratain MJ
    Eur J Cancer; 1998 Sep; 34(10):1493-9. PubMed ID: 9893619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
    Bosch TM; Meijerman I; Beijnen JH; Schellens JH
    Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer chemotherapy and drug metabolism enzyme].
    Xu F; Zhen YS; Shao RG
    Sheng Li Ke Xue Jin Zhan; 2005 Oct; 36(4):295-8. PubMed ID: 16408765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
    Bosch TM
    Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics in cancer chemotherapy: balancing toxicity and response.
    Donnelly JG
    Ther Drug Monit; 2004 Apr; 26(2):231-5. PubMed ID: 15228171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics in cancer etiology and chemotherapy.
    Boddy AV; Ratain MJ
    Clin Cancer Res; 1997 Jul; 3(7):1025-30. PubMed ID: 9815780
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic determinants of cancer drug efficacy and toxicity: practical considerations and perspectives.
    Candelaria M; Taja-Chayeb L; Arce-Salinas C; Vidal-Millan S; Serrano-Olvera A; Dueñas-Gonzalez A
    Anticancer Drugs; 2005 Oct; 16(9):923-33. PubMed ID: 16162969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited variations in drug-metabolizing enzymes: significance in clinical oncology.
    Iyer L
    Mol Diagn; 1999 Dec; 4(4):327-33. PubMed ID: 10671643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
    Hasegawa Y
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug metabolizing enzymes and their inhibitors' role in cancer resistance.
    Pathania S; Bhatia R; Baldi A; Singh R; Rawal RK
    Biomed Pharmacother; 2018 Sep; 105():53-65. PubMed ID: 29843045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer pharmacogenetics.
    Marsh S; McLeod HL
    Br J Cancer; 2004 Jan; 90(1):8-11. PubMed ID: 14710198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-metabolizing enzymes: role in drug resistance in cancer.
    Kaur G; Gupta SK; Singh P; Ali V; Kumar V; Verma M
    Clin Transl Oncol; 2020 Oct; 22(10):1667-1680. PubMed ID: 32170639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Classical oxazaphosphorines--metabolism and therapeutic properties--new implications].
    Sloderbach A; Górska A; Sikorska M; Misiura K; Hładoń B
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1235-53. PubMed ID: 24379264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing relevance of pharmacogenetics of drug metabolism in clinical practice.
    Pillans PI
    Intern Med J; 2001 Nov; 31(8):476-8. PubMed ID: 11720061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of drug-metabolising enzymes in clinical responses to chemotherapy.
    Scripture CD; Figg WD; Sparreboom A
    Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):17-25. PubMed ID: 16863465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of cytotoxic drugs.
    Daly AK; Hall AG
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):301-8. PubMed ID: 12113035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer pharmacogenomics: current and future applications.
    Watters JW; McLeod HL
    Biochim Biophys Acta; 2003 Mar; 1603(2):99-111. PubMed ID: 12618310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxicogenetics and toxicogenomics. Relevance and application in occupational health].
    Schulz T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):1004-10. PubMed ID: 17013775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
    van Schaik RH
    Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
    Oscarson M
    Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.